Chief
David S. Schrump, M.D., M.B.A.

Center for Cancer Research
National Cancer Institute

Building 10, Room 4-3942
Bethesda, MD 20892-1201
240-858-7000

The Thoracic Surgery Branch (TSB) conducts laboratory research pertaining to mechanisms of initiation and progression of thoracic malignancies; translates results of laboratory research to clinical protocols examining novel strategies to improve detection, diagnosis, and treatment of these neoplasms; mentors future leaders in thoracic surgical oncology and translational cancer research; and provides comprehensive clinical support for all patients with thoracic surgical issues at the NIH Clinical Center.


Patient Services


As part of our approach to patient care, we provide a number of natural history and treatment protocols for thoracic cancers. For instance, we offer molecular analysis of tumors, targeted drug therapies and innovative surgical procedures. Patients are provided guidance and assistance with appointments, travel, counseling and social support. We believe it is important to collaborate with our patients’ primary care physicians in order to provide expert continuity of care. Before visiting, patients may be asked to provide medical records, disks with scans or x-ray studies, and a list of medications. Important facts for our patients:

  • Consultations are provided at no cost to the patient
  • After a patient is accepted onto a study, treatments and tests performed at NIH are also no cost to the patient
  • NIH does not cover the cost of medical services provided at other facilities
  • We are located in Bethesda, Maryland, approximately 8 miles northwest of Washington, D.C.
  • Our clinics are located in the NIH Clinical Center (Building 10)
  • Visitor information is available at NIH Clinical Center

Frequently Asked Questions (FAQs)

Questions?  Visit NIH Clinical Research Trials and You.


Administrative Offices:

David S. Schrump, M.D., Chief
Thoracic and General Surgical Oncology
240-858-7000

 

Patient Referrals

Our oncology nurses, nurse practitioners and patient care coordinators can help you understand the rationale behind our clinical trials. Their knowledge and expertise helps guide patients and their families through our clinical protocols and provides reassurance by carefully explaining treatment plans. When surgery is indicated, state-of-the-art procedures are explained by surgeons with expertise in the field of oncology. Skilled physicians and allied professionals in genetics, nutrition, pharmacology, nuclear imaging, interventional radiology and gastroenterology are all part of the multi-disciplinary management of our patients.


Please visit “Our Clinical Trials” or “Key Staff” for specific contact information.

Physicians, Thoracic Oncology:

Research Nurses and Nurse Practitioners:

  • Colleen Bond, Cara Kenney, Tricia Kunst, Cheryl Warga
  • Patient Care Coordinator:
    • Claudia Espinoza
  • Staff Scientists, Visiting Fellows and Biologists:
  • Data Manager:
    •   Rupa Mahat
  • Administrative Staff:
    • Jan Pappas

Research Interests of Branch Members


Dr. David Schrump is a thoracic surgeon who is internationally recognized for surgical expertise pertaining to lung and esophageal cancers, malignant pleural mesothelioma, chest wall sarcomas and pulmonary metastases. His research efforts are focused on the elucidation of epigenetic mechanisms of gene regulation in lung and esophageal cancers and malignant pleural mesothelioma, and the development of epigenetic regimens including chromatin remodeling agents and novel tumor vaccines for the treatment of these neoplasms.

Dr. Chuong Dinh Hoang focuses on thoracic surgical oncology, with emphasis on malignant mesothelioma and thymic neoplasms. His clinical expertise includes all major aspects of thoracic surgery including procedures for lung cancer, other primary lung tumors, mesothelioma, thymic malignancies, esophageal cancer, pulmonary metastases, Pancoast tumors, and tracheal cancers.  He is developing a research effort aimed at translating deranged microRNA profiles unique to mesothelioma and other thoracic cancers for biomarker discovery and novel therapeutic strategies.

Dr. Haobin Chen is developing novel epigenetic therapies for small cell lung cancer.  He is board certified in both internal medicine and medical oncology.

About

The Thoracic Surgery Branch (TSB) conducts laboratory research pertaining to mechanisms of initiation and progression of thoracic malignancies; translates results of laboratory research to clinical protocols examining novel strategies to improve detection, diagnosis, and treatment of these neoplasms; mentors future leaders in thoracic surgical oncology and translational cancer research; and provides comprehensive clinical support for all patients with thoracic surgical issues at the NIH Clinical Center.

Referrals

Administrative Offices:

David S. Schrump, M.D., Chief
Thoracic and General Surgical Oncology
240-858-7000

 

Patient Referrals

Our oncology nurses, nurse practitioners and patient care coordinators can help you understand the rationale behind our clinical trials. Their knowledge and expertise helps guide patients and their families through our clinical protocols and provides reassurance by carefully explaining treatment plans. When surgery is indicated, state-of-the-art procedures are explained by surgeons with expertise in the field of oncology. Skilled physicians and allied professionals in genetics, nutrition, pharmacology, nuclear imaging, interventional radiology and gastroenterology are all part of the multi-disciplinary management of our patients.


Please visit “Our Clinical Trials” or “Key Staff” for specific contact information.

For Patients


Patient Services


As part of our approach to patient care, we provide a number of natural history and treatment protocols for thoracic cancers. For instance, we offer molecular analysis of tumors, targeted drug therapies and innovative surgical procedures. Patients are provided guidance and assistance with appointments, travel, counseling and social support. We believe it is important to collaborate with our patients’ primary care physicians in order to provide expert continuity of care. Before visiting, patients may be asked to provide medical records, disks with scans or x-ray studies, and a list of medications. Important facts for our patients:

  • Consultations are provided at no cost to the patient
  • After a patient is accepted onto a study, treatments and tests performed at NIH are also no cost to the patient
  • NIH does not cover the cost of medical services provided at other facilities
  • We are located in Bethesda, Maryland, approximately 8 miles northwest of Washington, D.C.
  • Our clinics are located in the NIH Clinical Center (Building 10)
  • Visitor information is available at NIH Clinical Center

Frequently Asked Questions (FAQs)

Questions?  Visit NIH Clinical Research Trials and You.


Teams

Physicians, Thoracic Oncology:

Research Nurses and Nurse Practitioners:

  • Colleen Bond, Cara Kenney, Tricia Kunst, Cheryl Warga
  • Patient Care Coordinator:
    • Claudia Espinoza
  • Staff Scientists, Visiting Fellows and Biologists:
  • Data Manager:
    •   Rupa Mahat
  • Administrative Staff:
    • Jan Pappas

Our Science


Research Interests of Branch Members


Dr. David Schrump is a thoracic surgeon who is internationally recognized for surgical expertise pertaining to lung and esophageal cancers, malignant pleural mesothelioma, chest wall sarcomas and pulmonary metastases. His research efforts are focused on the elucidation of epigenetic mechanisms of gene regulation in lung and esophageal cancers and malignant pleural mesothelioma, and the development of epigenetic regimens including chromatin remodeling agents and novel tumor vaccines for the treatment of these neoplasms.

Dr. Chuong Dinh Hoang focuses on thoracic surgical oncology, with emphasis on malignant mesothelioma and thymic neoplasms. His clinical expertise includes all major aspects of thoracic surgery including procedures for lung cancer, other primary lung tumors, mesothelioma, thymic malignancies, esophageal cancer, pulmonary metastases, Pancoast tumors, and tracheal cancers.  He is developing a research effort aimed at translating deranged microRNA profiles unique to mesothelioma and other thoracic cancers for biomarker discovery and novel therapeutic strategies.

Dr. Haobin Chen is developing novel epigenetic therapies for small cell lung cancer.  He is board certified in both internal medicine and medical oncology.

News